- Previous Close
14.50 - Open
14.50 - Bid 13.79 x --
- Ask 13.80 x --
- Day's Range
13.70 - 14.50 - 52 Week Range
11.00 - 20.61 - Volume
2,311,822 - Avg. Volume
2,668,838 - Market Cap (intraday)
6.428B - Beta (5Y Monthly) --
- PE Ratio (TTM)
21.55 - EPS (TTM)
0.64 - Earnings Date --
- Forward Dividend & Yield 0.43 (3.12%)
- Ex-Dividend Date May 22, 2024
- 1y Target Est
--
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was incorporated in 2001 and is based in Wuhan, China.
www.kqbio.comRecent News: 688526.SS
View MorePerformance Overview: 688526.SS
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688526.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688526.SS
View MoreValuation Measures
Market Cap
6.43B
Enterprise Value
5.43B
Trailing P/E
21.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.13
Price/Book (mrq)
1.67
Enterprise Value/Revenue
6.01
Enterprise Value/EBITDA
15.55
Financial Highlights
Profitability and Income Statement
Profit Margin
33.16%
Return on Assets (ttm)
3.30%
Return on Equity (ttm)
7.83%
Revenue (ttm)
902.14M
Net Income Avi to Common (ttm)
299.11M
Diluted EPS (ttm)
0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
1.07B
Total Debt/Equity (mrq)
1.65%
Levered Free Cash Flow (ttm)
119.37M